Sensato Investors’s Boston Scientific BSX Stock Holding History

Sensato Investors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-88,100	Closed	-$2.41M	–	90
2018 Q1	$2.41M	Buy	+88,100	New	+$2.39M	0.37%	53

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Sensato Investors's BSX Position: Q2 2018 in Review

Sensato Investors sold out of Boston Scientific (BSX) in Q2 2018, closing a stake of 88,100 shares — an estimated $2.41M sold.

Sensato Investors first reported a position in BSX in Q1 2018 and held it in 1 quarter. The position peaked at $2.41M in Q1 2018. 671 funds tracked by Wall St. Rank hold BSX as of Q2 2018.

Sensato Investors reported no remaining Boston Scientific position as of Q2 2018 after selling out during the quarter.
Sensato Investors sold 88,100 Boston Scientific shares in Q2 2018, an estimated $2.41M.
Sensato Investors first reported a position in Boston Scientific in Q1 2018 and held it in 1 quarter.
Sensato Investors's Boston Scientific position peaked at $2.41M in Q1 2018.
671 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2018.

Based on Sensato Investors's 13F filing for Q2 2018, filed 14 Aug 2018.